Skip to main content

Table 1 Demographics and substance habits that study participants report prior to incarceration

From: Overdose prevention training with naloxone distribution in a prison in Oslo, Norway: a preliminary study

 

N (%)

Gender, males

31 (100)

Age, mean (SD)

35.6 (9.3)

Frequency of opioid use

 Daily

9 (29)

 Almost daily

2 (6.5)

 Previously

13 (41.9)

 Never

7 (22.6)

Detoxification occurred in last 30 days

2 (6.5)

Receiving OMT

15 (48.3)

Uses drugs alone

 Sometimes

7 (22.6)

 Often

4 (12.9)

 Most of the time

2 (6.5)

 All of the time

1 (3.2)

 Never

2 (6.5)

 Missing/not applicable

15 (48.3)

Mixes opioids witha

 Alcohol

5 (16.1)

 Benzodiazepines

10 (32.3)

 Cocaine

2 (6.5)

 Methamphetamine

13 (41.9)

 GHB/GBL

4 (12.9)

 Other

2 (6.5)

Mode of administration

 Injecting

14 (45.2)

 Smoking

1 (3.2)

 Snorting

1 (3.2)

 No response

15 (48.4)

Witnessed an overdose previously

 1–10 times

13 (41.9)

 11–20 times

5 (16.1)

 More than 20 times

11 (35.5)

 Never

2 (6.5)

Experienced an overdose personally

 1–10 times

14 (45.2)

 11–20 times

4 (12.9)

 More than 20 times

3 (9.6)

 Never

10 (32.3)

  1. SD standard deviation, OMT opioid maintenance treatment, CPR cardio-pulmonary resuscitation, GHB/GBL gamma hydroxybutyrate/gamma butyrolactone
  2. aMultiple responses possible